Chuntao Wang, Zi-Hao Liao, Rui Wu*, Kai Chen* and Shifa Zhu*,
{"title":"Rh2(II)催化1,6-烯环异构化对映选择性合成1-二氢苯卓类药物","authors":"Chuntao Wang, Zi-Hao Liao, Rui Wu*, Kai Chen* and Shifa Zhu*, ","doi":"10.1021/jacs.5c0005310.1021/jacs.5c00053","DOIUrl":null,"url":null,"abstract":"<p >The 1-dihydrobenzazepine skeleton has emerged as a privileged structural motif in bioactive molecules. However, due to a lack of asymmetric methodology, access to chiral 1-dihydrobenzazepines has remained limited. Herein, we report the first intermolecular asymmetric cycloisomerization of benzo-fused enynes for the synthesis of chiral 1-dihydrobenzazepines via dirhodium catalysis. This methodology features high efficiency (up to 98% yield), high enantioselectivity (up to 99% ee), and broad scope of nucleophiles, including oxygen nucleophiles (alcohols, phenols, and carboxylic acids) and carbon nucleophiles (silyl enol ethers). Theoretical and experimental mechanistic studies reveal that the reaction pathway encompasses an asymmetric cycloisomerization, which gives rise to a dirhodium carbene containing a donor–acceptor (D-A) cyclopropane moiety, followed by a ring-opening process and stereoselective nucleophilic attack by external nucleophiles on the cyclopropyl ring. Control experiments demonstrate the pivotal role of the terminal group capped on the alkynyl group of substrates in achieving good efficiency.</p>","PeriodicalId":49,"journal":{"name":"Journal of the American Chemical Society","volume":"147 12","pages":"10560–10569 10560–10569"},"PeriodicalIF":15.6000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Enantioselective Synthesis of 1-Dihydrobenzazepines through Rh2(II)-Catalyzed Cycloisomerization of 1,6-Enyne\",\"authors\":\"Chuntao Wang, Zi-Hao Liao, Rui Wu*, Kai Chen* and Shifa Zhu*, \",\"doi\":\"10.1021/jacs.5c0005310.1021/jacs.5c00053\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The 1-dihydrobenzazepine skeleton has emerged as a privileged structural motif in bioactive molecules. However, due to a lack of asymmetric methodology, access to chiral 1-dihydrobenzazepines has remained limited. Herein, we report the first intermolecular asymmetric cycloisomerization of benzo-fused enynes for the synthesis of chiral 1-dihydrobenzazepines via dirhodium catalysis. This methodology features high efficiency (up to 98% yield), high enantioselectivity (up to 99% ee), and broad scope of nucleophiles, including oxygen nucleophiles (alcohols, phenols, and carboxylic acids) and carbon nucleophiles (silyl enol ethers). Theoretical and experimental mechanistic studies reveal that the reaction pathway encompasses an asymmetric cycloisomerization, which gives rise to a dirhodium carbene containing a donor–acceptor (D-A) cyclopropane moiety, followed by a ring-opening process and stereoselective nucleophilic attack by external nucleophiles on the cyclopropyl ring. Control experiments demonstrate the pivotal role of the terminal group capped on the alkynyl group of substrates in achieving good efficiency.</p>\",\"PeriodicalId\":49,\"journal\":{\"name\":\"Journal of the American Chemical Society\",\"volume\":\"147 12\",\"pages\":\"10560–10569 10560–10569\"},\"PeriodicalIF\":15.6000,\"publicationDate\":\"2025-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Chemical Society\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/jacs.5c00053\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Chemical Society","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/jacs.5c00053","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Enantioselective Synthesis of 1-Dihydrobenzazepines through Rh2(II)-Catalyzed Cycloisomerization of 1,6-Enyne
The 1-dihydrobenzazepine skeleton has emerged as a privileged structural motif in bioactive molecules. However, due to a lack of asymmetric methodology, access to chiral 1-dihydrobenzazepines has remained limited. Herein, we report the first intermolecular asymmetric cycloisomerization of benzo-fused enynes for the synthesis of chiral 1-dihydrobenzazepines via dirhodium catalysis. This methodology features high efficiency (up to 98% yield), high enantioselectivity (up to 99% ee), and broad scope of nucleophiles, including oxygen nucleophiles (alcohols, phenols, and carboxylic acids) and carbon nucleophiles (silyl enol ethers). Theoretical and experimental mechanistic studies reveal that the reaction pathway encompasses an asymmetric cycloisomerization, which gives rise to a dirhodium carbene containing a donor–acceptor (D-A) cyclopropane moiety, followed by a ring-opening process and stereoselective nucleophilic attack by external nucleophiles on the cyclopropyl ring. Control experiments demonstrate the pivotal role of the terminal group capped on the alkynyl group of substrates in achieving good efficiency.
期刊介绍:
The flagship journal of the American Chemical Society, known as the Journal of the American Chemical Society (JACS), has been a prestigious publication since its establishment in 1879. It holds a preeminent position in the field of chemistry and related interdisciplinary sciences. JACS is committed to disseminating cutting-edge research papers, covering a wide range of topics, and encompasses approximately 19,000 pages of Articles, Communications, and Perspectives annually. With a weekly publication frequency, JACS plays a vital role in advancing the field of chemistry by providing essential research.